Literature DB >> 28216993

Use of Tracking and Reminder Systems for Colorectal Cancer Screening in Indian Health Service and Tribal Facilities.

J A Craig1, Diana Redwood1, Ellen Provost1, Donald Haverkamp2, D K Espey2.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is a significant cause of morbidity and mortality among American Indian/Alaska Native (AI/AN) people. Screening at recommended intervals can detect CRC in its early, most treatable stages, or prevent CRC through removal of precancerous polyps. However, CRC screening percentages remain low among AI/AN people. Reminder and tracking systems can be used to improve CRC screening percentages.
PURPOSE: In this study we assessed the prevalence of CRC screening reminder and tracking systems in Indian Health Service (IHS), Tribal, or Urban (I/T/U) health facilities.
METHODS: A telephone survey of randomly selected small, medium and large I/T/U health facilities nationwide was conducted. Three health facilities from each of the 12 IHS areas nationwide were selected from a list of I/T/U healthcare facilities that provide CRC screening or refer patients to another facility for screening, with the goal of having one small, one medium, and one large I/T/U health facility from each IHS area.
RESULTS: Thirty-four facilities (94%) participated in the telephone survey between April 1 and September 24, 2010. All facilities used the IHS Resource and Patient Management System to manage their patient care, and 82% used the Electronic Health Record (EHR) version. Over half of these facilities (55%) performed in-office fecal occult blood tests (FOBT) collected during a digital rectal exam, all of which reported that they also sent FOBT cards home with patients. Fifty-three percent of facilities used an opportunistic, visit-based approach to CRC screening. Nearly a third (32%) of facilities reported using a reminder system to notify patients that they were due for CRC screening. Almost two-thirds (65%) of facilities used a reminder system to notify health care providers that patients were due for CRC screening. While 73% of facilities used a system to track whether patients were due for CRC screening, only 61% used a system to track patient results for CRC screening, and 42% used a system to track patients with a personal history of polyps or CRC.
CONCLUSIONS: A majority of facilities performed in-office FOBT tests using a digital rectal exam, which is a practice that is contrary to national CRC screening recommendations. Additionally, the majority of facilities reported not using an organized system for CRC screening. Use of patient reminders was suboptimal. However, facilities did report use of provider reminders, tracking when patients were due for CRC screening, and tracking CRC screening results. As the EHR system becomes more widely used and established, I/T/U facilities could be encouraged to increase their use of the EHR tools available to aid in systematically increasing CRC screening percentages.

Entities:  

Year:  2015        PMID: 28216993      PMCID: PMC5315090     

Source DB:  PubMed          Journal:  IHS Prim Care Provid        ISSN: 1063-4398


  18 in total

Review 1.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin
Journal:  Gastroenterology       Date:  2012-07-03       Impact factor: 22.682

2.  Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial.

Authors:  Thomas D Denberg; John M Coombes; Tim E Byers; Alfred C Marcus; Lawrence E Feinberg; John F Steiner; Dennis J Ahnen
Journal:  Ann Intern Med       Date:  2006-12-19       Impact factor: 25.391

3.  A survey of Indian Health Service and tribal health providers' colorectal cancer screening knowledge, perceptions, and practices.

Authors:  Donald Haverkamp; David G Perdue; David Espey; Nathaniel Cobb
Journal:  J Health Care Poor Underserved       Date:  2011-02

4.  Geographic variation in colorectal cancer incidence and mortality, age of onset, and stage at diagnosis among American Indian and Alaska Native people, 1990-2009.

Authors:  David G Perdue; Donald Haverkamp; Carin Perkins; Christine Makosky Daley; Ellen Provost
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

Review 5.  Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders.

Authors:  Roy C Baron; Stephanie Melillo; Barbara K Rimer; Ralph J Coates; Jon Kerner; Nancy Habarta; Sajal Chattopadhyay; Susan A Sabatino; Randy Elder; Kimberly Jackson Leeks
Journal:  Am J Prev Med       Date:  2010-01       Impact factor: 5.043

6.  Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patients with a positive fecal immunochemical test.

Authors:  Jae Myung Cha; Joung Il Lee; Kwang Ro Joo; Hyun Phil Shin; Jae Jun Park
Journal:  Dig Dis Sci       Date:  2011-06-18       Impact factor: 3.199

7.  Physician recommendations for follow-up of positive fecal occult blood tests.

Authors:  K Robin Yabroff; Carrie N Klabunde; Ron Myers; Martin L Brown
Journal:  Med Care Res Rev       Date:  2005-02       Impact factor: 3.929

8.  Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.

Authors:  Marion R Nadel; Zahava Berkowitz; Carrie N Klabunde; Robert A Smith; Steven S Coughlin; Mary C White
Journal:  J Gen Intern Med       Date:  2010-04-10       Impact factor: 5.128

9.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

10.  Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Authors:  Ann G Zauber; Iris Lansdorp-Vogelaar; Amy B Knudsen; Janneke Wilschut; Marjolein van Ballegooijen; Karen M Kuntz
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.